Philips unveils new EPIQ Elite ultrasound line, with vascular imaging capabilities

Philips building
Philips’ solution produces 3D images that allow clinicians to see into a vessel to spot plaque and assess flow data over time. (Philips)

Philips has launched its new EPIQ Elite ultrasound system, offering a range of diagnostic solutions for different medical specialties, including the company’s first for vascular assessments.

"With one in four stroke cases caused by vascular disease of the carotid artery in the neck, vascular health is a growing concern worldwide,” said Jeff Cohen, business leader of Philips’ general imaging and women's healthcare ultrasound divisions, describing ultrasound as the ideal imaging technology for a precise diagnosis.

Philips’ solution employs its xMATRIX linear transducer to produce 3D images of the patient’s vasculature, allowing clinicians to see into a vessel to evaluate plaque location and composition as well as flow data to assess stenotic conditions. The system also allows clinicians to acquire two planes simultaneously, which the company said improves accuracy and can reduce exam time by 20%.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

"Our new portfolio of dedicated systems and solutions based on the EPIQ Elite combines new display technology, innovative transducers, advanced software and enhanced processing power," Cohen added.

Philips EPIQ vascular ultrasound. (Image: Philips)

In obstetrics and gynecology, Philips said the EPIQ Elite system provides lifelike 3D scans to offer improved detection of birth defects and potential complications during all stages of pregnancy. The system, along with Philips’ TrueVue technology, allows the clinician to move a virtual light source around the 3D images of the fetus to provide high levels of detail.

RELATED: Special Report—The top 10 medtech companies of 2024 | Philips

Late last year, Philips unveiled its first dedicated breast ultrasound solution, combining screening, elastography, precision biopsy and visual mapping tools, available with the Philips EPIQ and Affiniti systems.

It includes automated visual mapping and annotation software, to help provide full coverage of the breast during the acquisition procedure. Its elastography hardware also helps provide more information on the stiffness of breast tissue and creates a color-coded map of the results.

Suggested Articles

Bio-Rad Laboratories received FDA clearance for two digital PCR products designed to monitor CML patients’ molecular responses to treatment.

Neuspera Medical raised a total of $26 million through the second tranche of a series B round, to fund clinical testing programs for its implants.

Voyager stands to receive up to $728 million in milestones for each compound AbbVie chooses to advance beyond phase 1.